Log In Sign up
The largest database of trusted experimental protocols
> Living Beings > Professional or Occupational Group > Primary Care Physicians

Primary Care Physicians

Primary Care Physicians are medical professionals who provide comprehensive, continuous care to patients of all ages.
They serve as the first point of contact for individuals seeking medical attention, diagnosing and treating a wide range of health conditions, and coordinating referrals to specialists as needed.
Primary Care Physcians play a crucial role in preventive healthcare, promoting wellness, and managing chronic diseases.
They employ a patient-centered approach, focusing on the unique needs and preferences of each individual to deliver high-quality, personalized care.
With their broad medical knowledge and strong patient relationships, Primary Care Physicians are essential in maintaining the overall health and well-being of their communities.

Most cited protocols related to «Primary Care Physicians»

1
Updating Costing Manual Alignment
Changes to the content of the costing manual that were made to align with the new health economic guidelines included incorporating a new typology of costs and consequently updating the roadmap for costing studies. The roadmap describes the steps that are needed to conduct a costing study [4 (link)]. It serves as a starting point for conducting costing studies and connects the health economic guidelines to the costing manual.
Reference prices for health care consumption, which are average unit costs, constitute a frequently used part of the costing manual. Reference prices were recalculated using recent information on costs, volume and prices for various types of health care services. Reference prices were updated using various techniques (summarized in Table 1), depending on data availability. If possible, bottom-up microcosting was used to calculate reference prices, as this is the gold standard for calculating cost prices [5 (link)]. When bottom-up microcosting data was not available, grosscosting methods were applied to calculate reference prices. Bottom-up microcosting studies, identifying and valuating resource use per individual patient, were used to calculate references prices for hospital care [Tan, S.S., et al. Reference unit prices for surgery, neurology and paediatrics. Submitted for publication]. Reference prices for emergency care, ambulances, blood products, daycare treatment in mental health care and rehabilitation were calculated using top-down grosscosting, for which data on costs and volumes were derived from health care providers. Data on expenditures and volumes derived from national health care database were used to calculate reference prices using top-down grosscosting, for primary care physicians, paramedical care, elderly care, home care, mental health care and health care for disabled patients [6 ]. Finally, tariffs were used to value diagnostic procedures [7 ]. For contacts with independent psychotherapists and psychiatrists, ambulatory consultation in a general institution and inpatients days in mental health care tariffs were used [8 ]. Relevant stakeholders were consulted to validate the updated reference prices. Updated informal care costs were derived from the website of the Central Administration Office (CAK). Productivity costs should be valued using the friction cost method based on the Dutch health economic guidelines. The friction period is equal to the average duration of a job vacancy plus an additional four weeks. The average duration of job vacancies was calculated with the following formula: 365 / (the number of filled vacancies in one year / the number of vacancies at a moment in that same year). The number of vacancies was derived from the website of Statistics Netherlands. Wage levels were also derived from the Statistics Netherlands website.
Kanters T.A., Bouwmans C.A., van der Linden N., Tan S.S, & Hakkaart-van Roijen L. (2017). Update of the Dutch manual for costing studies in health care. PLoS ONE, 12(11), e0187477.
Full text: Click here
Publication 2017
Aged Ambulances BLOOD Day Care, Medical Friction Gold Health Services Administration Informal care Inpatient Mental Health Operative Surgical Procedures Patients Primary Care Physicians Psychiatrist Psychotherapists Rehabilitation Service, Emergency Medical Tests, Diagnostic Vaginal Diaphragm
2
Cross-sectional survey of prediabetes in Singapore
This occurred in 8 out of 20 polyclinics in Singapore between July 2017 and January 2018. Polyclinics are public healthcare institutions where primary care doctors and other healthcare professionals such as dietitians and nurses deliver medical care. Approximately half of the patient population with chronic illnesses in Singapore are treated in this setting [26 (link)]. During the time when the study was conducted, the polyclinics were managed by 2 public healthcare organisations, SingHealth and National Healthcare Group (NHG). There were 9 polyclinics under NHG and 11 polyclinics under SingHealth. Upon invitation, NHG agreed to participate. Eight out of the 9 polyclinics participated while the other one declined due to operational constraints.
For the cross-sectional survey, the inclusion criteria were (i) community-dwelling patients with existing prediabetes who were Singapore citizens or Singapore Permanent Residents, aged 21 to 79 years, (ii) diagnosis verified by oral glucose tolerance test (OGTT) and diagnosis code, and (iii) currently following up at any one of the 8 polyclinics. Individuals who had converted back to normoglycemia or progressed to diabetes based on the last diagnosis code and laboratory test were excluded. The polyclinic headquarter database formed the sampling frame, where patients with a diagnosis code of “impaired fasting glycaemia (IFG)” or “impaired glucose tolerance (IGT)” without “diabetes mellitus” were identified. We adopted the definitions of IFG and IGT from the World Health Organisation (WHO) [27 ]. Time location sampling was conducted at the polyclinic level. This meant that participants were recruited from the 8 different polyclinic venues at different times of the day, throughout the operating hours on weekdays and Saturdays (closed on Sundays). Individuals who want to undergo any testing or see a healthcare professional in polyclinics have to make prior appointments. Based on a pre-determined sampling frame, field recruiters would wait at the specific polyclinic and invite patients who turned up for their appointments to participate. These appointments need not necessary be for prediabetes follow-up, and could be for any reason.
Lim R.B., Wee W.K., For W.C., Ananthanarayanan J.A., Soh Y.H., Goh L.M., Tham D.K, & Wong M.L. (2020). Correlates, facilitators and barriers of physical activity among primary care patients with prediabetes in Singapore – a mixed methods approach. BMC Public Health, 20, 1.
Full text: Click here
Publication 2020
Diabetes Mellitus Diagnosis Dietitian Disease, Chronic Health Care Professionals Health Personnel Intolerances, Glucose Nurses Oral Glucose Tolerance Test Patients Primary Care Physicians Reading Frames States, Prediabetic
3
Aspirin for Older Adults in Australia and USA
The trial involved men and women from Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) (Tables S1 and S2 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Details regarding the trial methods have been published previously,13 (link) and the protocol is available at NEJM.org. In brief, participants were randomly assigned to receive 100 mg of enteric-coated aspirin daily or matching placebo. In Australia, recruitment involved collaboration with the participant’s usual primary care physician. In the United States, recruitment was community-based through academic health centers. The trial intervention was stopped on June 12, 2017, at the request of the funding agency, the National Institute on Aging, because results of conditional power analyses indicated that it was extremely unlikely that continuation of the trial intervention would reveal a benefit with regard to the primary end point.1 (link) The decision was made during regular monitoring of trial progress and was not part of a preplanned interim analysis. All the results reported in this article were based on deaths that occurred in participants before the date of cessation of the trial intervention.
McNeil J.J., Nelson M.R., Woods R.L., Lockery J.E., Wolfe R., Reid C.M., Kirpach B., Shah R.C., Ives D.G., Storey E., Ryan J., Tonkin A.M., Newman A.B., Williamson J.D., Margolis K.L., Ernst M.E., Abhayaratna W.P., Stocks N., Fitzgerald S.M., Orchard S.G., Trevaks R.E., Beilin L.J., Donnan G.A., Gibbs P., Johnston C.I., Radziszewska B., Grimm R, & Murray A.M. (2018). Effect of Aspirin on All-Cause Mortality in the Healthy Elderly. The New England journal of medicine, 379(16), 1519-1528.
Publication 2018
Aspirin Hispanics Negroes Placebos Primary Care Physicians Woman
4
Swiss Population Health Insurance Data
Medical claims data were used from Helsana, covering about 1.3 million Swiss residents with mandatory health insurance. Population characteristics comprised gender, age, regional variables (e.g. language area) and the type of health insurance plan (managed care model, accident coverage, type of deductible class). The database also included information on health care visits, prescription drugs and drug costs. Drug data were based on medications prescribed in the outpatient setting including prescribed drugs which were purchased directly at the pharmacy. The outpatient setting comprised practice-based primary care physicians and specialists, as well as physicians from ambulatories, outpatient clinics and walk-in clinics. In our database, all prescribed drug items were coded according to the WHO ATC classification system [23 ]. Our (drug) data are highly reliable because the collected insurance claims covered almost all health care and pharmacy invoices. Since about 3% of the invoices were directly paid by the patient and not submitted for reimbursement, only a small percentage of invoices could not considered in our analyses. Permission to access the study data was provided by the Helsana Group.
Huber C.A., Szucs T.D., Rapold R, & Reich O. (2013). Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health, 13, 1030.
Full text: Click here
Publication 2013
Accidents Gender Health Insurance Health Planning Managed Care Outpatients Patients Pharmaceutical Preparations Physicians Prescription Drugs Primary Care Physicians Specialists
5
Comprehensive Stroke Case Ascertainment Protocol
Procedures for complete case capture follow international recommendations for capture–recapture and multiple source ascertainment methods.20 (link) Cases are primarily identified through active pursuit of emergency department and directly admitted stroke patients using validated screening terms.21 (link) The abstractors also routinely canvass intensive care units and hospital floors searching for in-house strokes or those not ascertained through the screening logs. The active surveillance is supplemented by review of hospital passive listings of International Classification of Disease, 9th revision discharge codes for stroke (430–438; excluding 433.x0, 434.x0 [x = 1–9]; 437.0, 437.2, 437.3, 437.4, 437.5, 437.7, 437.8, and 438). County coroner records are screened for causes of sudden stroke death not presenting to the hospital. Several minor changes to case ascertainment procedures were made over the course of the project to maintain efficiency. In 2001, the following diagnostic terms were removed from the active surveillance list: dizziness, falling, imbalance, syncope, and trouble walking. These terms were found to be highly inefficient at identifying strokes, with a positive predict value of ≤1%. Starting January 1, 2001, a sample of Nueces County primary care and cardiology offices, as well as 95% of neurologist offices, were contacted frequently and encouraged to report stroke cases to our project. Abstractors reviewed and abstracted cases not previously screened. The sampling of primary care physicians and cardiologists was subsequently discontinued on January 31, 2004, because during the 3 years of the sampling only 13 ischemic stroke patients were identified exclusively from this method of 1,866 ischemic stroke cases identified in BASIC. Because 74 cases from the sample identified came from neurology offices, we did continue to identify these few stroke cases from neurology offices. From January 31, 2004 to July 31, 2008, only 71 strokes were identified via the neurology office of 1,971 ischemic stroke cases identified. In 2008, we therefore stopped screening neurology offices. From January 1, 2000 through December 1, 2007, BASIC identified cases through active surveillance of both the admissions log and emergency department (ED) log. A review of this methodology in 2007 using complete data from calendar year 2004 suggested that frequent passive ED surveillance in combination with active surveillance of admission logs successfully identifies ≥98% of all ischemic strokes. This new methodology was implemented on December 2, 2007. Finally, we were unable to obtain passive listings of stroke from 1 of the hospital systems for 6 months of 2008. In other 6-month periods, this never amounted to >5 cases. A sensitivity analysis was performed to determine the effects of the changes on incidence rate estimates and ethnic comparisons over time.
Cases are validated by neurologists or a stroke fellowship-trained emergency medicine physician, blinded to subjects’ ethnicity and age, using source documentation. Ischemic stroke diagnosis is based on published international clinical criteria20 (link) that require onset of a focal neurologic deficit following a defined vascular distribution without documented resolution within 24 hours (unless treated with recombinant tissue plasminogen activator) and not explainable by a nonvascular etiology. Imaging is used to discriminate ischemic stroke and hemorrhagic stroke. Because the use of brain MRI has increased greatly in the past 10 years, validators are required to use the original clinical criteria for case validation, so that trend data can be assessed without bias. Therefore, subjects having acute infarction on brain MRI without the clinical deficit described above are validated as no stroke.
Morgenstern L.B., Smith M.A., Sanchez B.N., Brown D.L., Zahuranec D.B., Garcia N., Kerber K.A., Skolarus L.E., Meurer W.J., Burke J.F., Adelman E.E., Baek J, & Lisabeth L.D. (2013). Persistent Ischemic Stroke Disparities despite Declining Incidence in Mexican Americans. Annals of neurology, 74(6), 778-785.
Publication 2013
Alteplase Blood Vessel Brain Brain Infarction Cardiologists Cardiovascular System Cerebrovascular Accident Coroners Diagnosis Ethnicity Fellowships Hemorrhagic Stroke Hypersensitivity Neurologists Patient Discharge Patients Physicians Primary Care Physicians Primary Health Care Stroke, Ischemic Syncope

Most recents protocols related to «Primary Care Physicians»

1
Ingestible Device for Ulcerative Colitis Treatment
Not available on PMC !

Example 12

As a proof of concept, the patient population of this study is patients that (1) have moderate to severe ulcerative colitis, regardless of extent, and (2) have had an insufficient response to a previous treatment, e.g., a conventional therapy (e.g., 5-ASA, corticosteroid, and/or immunosuppressant) or a FDA-approved treatment. In this placebo-controlled eight-week study, patients are randomized. All patient undergo a colonoscopy at the start of the study (baseline) and at week 8. Patients enrolled in the study are assessed for clinical status of disease by stool frequency, rectal bleeding, abdominal pain, physician's global assessment, and biomarker levels such as fecal calprotectin and hsCRP. The primary endpoint is a shift in endoscopy scores from Baseline to Week 8. Secondary and exploratory endpoints include safety and tolerability, change in rectal bleeding score, change in abdominal pain score, change in stool frequency, change in partial Mayo score, change in Mayo score, proportion of subjects achieving endoscopy remission, proportion of subjects achieving clinical remission, change in histology score, change in biomarkers of disease such as fecal calprotectin and hsCRP, level of adalimumab in the blood/tissue/stool, change in cytokine levels (e.g., TNFα, IL-6) in the blood and tissue.

FIG. 72 describes an exemplary process of what would occur in clinical practice, and when, where, and how the ingestible device will be used. Briefly, a patient displays symptoms of ulcerative colitis, including but not limited to: diarrhea, bloody stool, abdominal pain, high c-reactive protein (CRP), and/or high fecal calprotectin. A patient may or may not have undergone a colonoscopy with diagnosis of ulcerative colitis at this time. The patient's primary care physician refers the patient. The patient undergoes a colonoscopy with a biopsy, CT scan, and/or MRI. Based on this testing, the patient is diagnosed with ulcerative colitis. Most patients are diagnosed with ulcerative colitis by colonoscopy with biopsy. The severity based on clinical symptoms and endoscopic appearance, and the extent, based on the area of involvement on colonoscopy with or without CT/MRI is documented. Treatment is determined based on diagnosis, severity and extent.

For example, treatment for a patient that is diagnosed with ulcerative colitis is an ingestible device programmed to release a single bolus of a therapeutic agent, e.g., 40 mg adalimumab, in the cecum or proximal to the cecum. Prior to administration of the treatment, the patient is fasted overnight and is allowed to drink clear fluids. Four hours after swallowing the ingestible device, the patient can resume a normal diet. An ingestible device is swallowed at the same time each day. The ingestible device is not recovered.

In some embodiments, there may be two different ingestible devices: one including an induction dose (first 8 to 12 weeks) and a different ingestible device including a different dose or a different dosing interval.

In some examples, the ingestible device can include a mapping tool, which can be used after 8 to 12 weeks of induction therapy, to assess the response status (e.g., based on one or more of the following: drug level, drug antibody level, biomarker level, and mucosal healing status). Depending on the response status determined by the mapping tool, a subject may continue to receive an induction regimen or maintenance regimen of adalimumab.

In different clinical studies, the patients may be diagnosed with Crohn's disease and the ingestible devices (including adalimumab) can be programmed to release adalimumab in the cecum, or in both the cecum and transverse colon.

In different clinical studies, the patients may be diagnosed with illeocolonic Crohn's disease and the ingestible devices (including adalimumab) can be programmed to release adalimumab in the late jejunum or in the jejunum and transverse colon.

US11857669B2. Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2024-01-02). BIORA THERAPEUTICS, INC. [US]. Inventors: Mitchell Lawrence Jones [US], Sharat Singh [US], Christopher Loren Wahl [US], Harry Stylli [US].
Full text: Click here
Patent 2024
Abdominal Pain Adalimumab Adrenal Cortex Hormones Biological Markers Biopsy BLOOD Cecum Colonoscopy C Reactive Protein Crohn Disease Cytokine Diarrhea Diet Endoscopy Endoscopy, Gastrointestinal Feces Homo sapiens Immunoglobulins Immunosuppressive Agents Jejunum Leukocyte L1 Antigen Complex Medical Devices Mesalamine Mucous Membrane Neoadjuvant Therapy Patient Care Management Patients Pharmaceutical Preparations Placebos Primary Care Physicians Safety Therapeutics Tissues Transverse Colon Treatment Protocols Tumor Necrosis Factor-alpha Ulcerative Colitis X-Ray Computed Tomography
2
Teleophthalmology Screening for Diabetic Retinopathy
This retrospective medical chart review consisted of collecting data regarding diabetic patients 18 years and older who have participated in the teleophthalmology program offered throughout the state of WV between January 2017 and June 2019. The WVU institutional review board approved the study protocol. The Volk Pictor (Volk Optical, Inc., Mentor, OH, USA) nonmydriatic cameras used by trained nurses and staff acquired 45-degree fundus images from patients at various primary care and endocrinology clinic settings. In these settings, patients waited in rooms with the lights turned off to maximize pupillary dilation sans mydriatic drop administration. Staff would use the handheld fundus cameras to take photographs that were then uploaded and subsequently reviewed by retina specialists. Both eyes were photographed when possible with hopes of acquiring at least one viable image per eye. The number of attempts made was contingent on the judgment of the trained staff acquiring the images and the tolerance demonstrated by the patients being screened for repeated attempts.
Images were graded by a retina specialist at the WVU Eye Institute. These specialists included three WVU board-certified retina faculty and one vitreoretinal fellow—all patients were assigned to have their set of acquired images evaluated by one of these four specialists. Images were noted as gradable or ungradable, and the extent of DR (absent, mild, moderate, severe, or proliferative) and/or DME (absent, mild, moderate, or severe) was described in accordance to the International Classification of DR scale [24 (link)]. Care plan recommendations and suspicion of other pathologies were also noted. The results with their accompanying care plan recommendations were uploaded to the Epic electronic medical record (EMR) for the use of primary care physicians (PCPs) in their advising of diabetic patients in accordance to the American Academy of Ophthalmology’s guidelines for DR follow-up (Fig. 1). Referral recommendations were made in accordance to those proposed by the International Council of Ophthalmology (ICO) and American Diabetes Association (ADA) [25 (link)]—albeit with the decision to recommend referral for suspected DR of any severity. Recommendations could also be made on the basis of other ocular pathologies that were remarked by reviewing ophthalmologists (e.g., age-related macular degeneration, choroidal nevi, colobomas, hypertensive retinopathy, glaucomatous optic nerves). For the purpose of this study, we exclusively followed patients whose screening findings indicated suspicion for diabetic retinopathy of any severity in at least one eye.

Teleophthalmology flow chart

Schofield T., Patel A., Palko J., Ghorayeb G, & Laxson L.C. (2023). Diabetic retinopathy screenings in West Virginia: an assessment of teleophthalmology implementation. BMC Ophthalmology, 23, 93.
Full text: Click here
Publication 2023
Age-Related Macular Degeneration Choroid Coloboma Diabetes Mellitus Diabetic Retinopathy Ethics Committees, Research Faculty Glaucoma Hypertensive Retinopathy Immune Tolerance Light Mentors Mydriasis Mydriatics Nevus Nurses Ophthalmologists Optic Nerve Patients Pneumocystosis Primary Care Physicians Primary Health Care Retina Specialists System, Endocrine Vision
3
Reducing Participant Attrition in Home-Based Intervention
Participant attrition is a risk we will work to mitigate. First, by collaborating with the primary care physician for referrals, we will build participant trust in the intervention. Second, to reduce participant burden, we will offer flexible appointment times in the homes of participants and research staff will make reminder calls prior to appointments. Lastly, we are providing remuneration for each testing event. In the unforeseen event of loss of the unbiased study evaluator the PI will use funds to purchase an occupational therapist colleague’s time for follow-up testing.
Klinedinst T.C., Ciro C.A, & Kendzor D.E. (2023). A pilot, randomized, feasibility study to improve health self-management behaviors in older adults with multiple chronic conditions and functional limitations: Protocol for the Behavioral Activation and Occupational Therapy Trial (BA+OT). Journal of Multimorbidity and Comorbidity, 13, 26335565231163037.
Publication 2023
Occupational Therapist Primary Care Physicians Tooth Attrition
4
GPs' Perspectives on Open Notes Survey
We conducted an anonymous nationwide web-based survey of GPs in England (n=400; Multimedia Appendix 1). We used a convenience sample to solicit the opinions of participants using the membership of the clinician marketing service Doctors.net.uk [38 ]. This is the largest web-based medical network in the United Kingdom, with 248,326 (69.9%) registered doctors out of a total of 355,250 British doctors. Approximately, 21,250 (57.82%) GPs out of a total of 36,752 registered and working in the United Kingdom are active in the community during any 90-day period. Among those registered with Doctors.net.uk, a variable percentage of GPs active within the community also consented to being sent survey invitations via email. Depending on how GPs consented to receive survey invitations, our study was advertised via email or displayed on the Doctors.net.uk home pages of a quota sample of GPs between March 10 and 31, 2022. The sample was stratified according to sex, age, and geographic location using demographic information about registered GPs in England provided by the General Medical Council (GMC) in March 2022 [39 ]. Doctors.net.uk invited 720 GPs by email and also by invitations embedded in their Doctors.net.uk home pages; a further 2072 GPs were invited to participate only via links on their home pages. We obtained samples from Doctors.net.uk in previous studies using similar methods [40 (link),41 (link)].
The study team adapted a mixed methods survey instrument originally developed to explore US primary care physicians’ views and experiences with open notes [24 (link)]. This survey was adapted in consultation with GPs in England and piloted with GP colleagues in the United Kingdom (n=5) to ensure face validity. The survey was timed to take approximately 5 minutes to complete.
Blease C., Torous J., Dong Z., Davidge G., DesRoches C., Kharko A., Turner A., Jones R., Hägglund M, & McMillan B. (2023). Patient Online Record Access in English Primary Care: Qualitative Survey Study of General Practitioners’ Views. Journal of Medical Internet Research, 25, e43496.
Full text: Click here
Publication 2023
Physicians Primary Care Physicians
5
Survival and Consciousness Outcomes
The 30-day survival rate and 90-day consciousness rate were chosen as the primary outcomes. Mortality data were obtained from medical records or by telephone contact with primary care physicians or family members. Consciousness was determined based on the National Institutes of Health Stroke Scale (NIHSS) (item 1a: value 0, 1, or 2 for consciousness, value 3 for unconsciousness), which was obtained from a clinic visit at 90-day follow-up or by telephone contact by two trained neurosurgeons blinded to research data.
Zhou J., Wang R., Mao J., Gu Y., Shao A., Liu F, & Zhang J. (2023). Prognostic models for survival and consciousness in patients with primary brainstem hemorrhage. Frontiers in Neurology, 14, 1126585.
Full text: Click here
Publication 2023
Cerebrovascular Accident Clinic Visits Consciousness Family Member Neurosurgeon Primary Care Physicians

Top products related to «Primary Care Physicians»

1
Achieva magnet by Philips
The Achieva Magnet is a powerful magnetic resonance imaging (MRI) system designed by Philips. It is a core component of the Achieva MRI product line. The Achieva Magnet generates a strong, stable magnetic field that is used to acquire high-quality images of the human body for medical diagnosis and research purposes.
2
Sas version 9 by SAS Institute
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
3
Achieva magnet scanner by Philips
The Philips Achieva Magnet scanner is a magnetic resonance imaging (MRI) device used for medical diagnostic purposes. It generates a strong magnetic field and radio waves to create detailed images of the body's internal structures. The Achieva Magnet scanner provides healthcare professionals with the necessary tool to visualize and examine various organs and tissues for clinical evaluation and diagnosis.
4
Stata 13 by StataCorp
Sourced in United States, Denmark, United Kingdom, Austria, Sweden
Stata 13 is a comprehensive, integrated statistical software package developed by StataCorp. It provides a wide range of data management, statistical analysis, and graphical capabilities. Stata 13 is designed to handle complex data structures and offers a variety of statistical methods for researchers and analysts.
5
Stata 16 by StataCorp
Sourced in United States, United Kingdom, Austria
Stata 16 is a comprehensive statistical software package designed for data analysis, management, and visualization. It provides a wide range of tools and functionalities for researchers, academics, and professionals working with quantitative data. Stata 16 offers advanced statistical methods, data manipulation capabilities, and flexible programming features to support various analytical tasks.
6
Magna pure lc 2 by Roche
Sourced in United States, Switzerland, Germany, Italy
The MagNA Pure LC 2.0 is a fully automated, high-throughput nucleic acid purification system. It utilizes magnetic bead-based technology to efficiently extract and purify DNA, RNA, and viral nucleic acids from a variety of sample types.
7
Gif xp260 by Olympus
Sourced in Japan
The GIF-XP260 is a high-performance microscope camera from Olympus, designed for scientific imaging applications. It features a 26-megapixel CMOS sensor and delivers excellent image quality with fast data transfer capabilities.
8
Stata 14 by StataCorp
Sourced in United States, Denmark, United Kingdom, Belgium, Japan, Austria, China
Stata 14 is a comprehensive statistical software package that provides a wide range of data analysis and management tools. It is designed to help users organize, analyze, and visualize data effectively. Stata 14 offers a user-friendly interface, advanced statistical methods, and powerful programming capabilities.
9
Magna pure lc total nucleic acid isolation kit by Roche
Sourced in Germany, Switzerland, United States, Canada
The MagNA Pure LC Total Nucleic Acid Isolation Kit is a laboratory equipment product designed for the automated extraction and purification of total nucleic acids, including both DNA and RNA, from various sample types. The kit utilizes magnetic bead technology to capture and isolate the target nucleic acids, which can then be used for downstream applications such as PCR, sequencing, or other molecular biology techniques.
10
Gif n260 by Olympus
Sourced in Japan
The GIF-N260 is a high-performance microscope camera developed by Olympus. It is designed to capture high-quality digital images and video from microscope observations. The camera features a 6.4-megapixel sensor and can record at up to 60 frames per second, providing detailed and accurate representations of microscopic samples.

More about "Primary Care Physicians"

Primary Care Physicians (PCPs), Family Medicine Practitioners, General Practitioners, Family Doctors, Comprehensive Care Providers, Continuous Care Specialists, Community-based Clinicians, Preventive Health Champions, Patient-centered Care Experts, Chronic Disease Managers, Wellness Promoters, Referral Coordinators, Healthcare Generalists, All-ages Caregivers.
Primary Care Physicians (PCPs) are essential healthcare professionals who provide comprehensive, continuous care to patients of all ages.
Serving as the first point of contact for individuals seeking medical attention, PCPs diagnose and treat a wide range of health conditions, while also coordinating referrals to specialists as needed.
With their broad medical knowledge and strong patient relationships, PCPs play a crucial role in preventive healthcare, promoting wellness, and managing chronic diseases.
Utilizing a patient-centered approach, they focus on the unique needs and preferences of each individual to deliver high-quality, personalized care.
Whether you're looking to optimize your research protocols, locate the best products from the literature, or improve the efficiency of your workflow, PubCompare.ai can assist Primary Care Physicians like yourself in leveraging the power of AI-driven comparisons.
Experience the benefits of AI-assisted protocol optimization today and elevate your research to new heights.
Primary Care Physcians are essential in maintaining the overall health and well-being of their communities, serving as trusted partners in their patients' healthcare journeys.